Evidence map›Paper›PMID 30586894›Full record

Trial reportNutrients2018

Moderate Protein Restriction in Advanced CKD: A Feasible Option in An Elderly, High-Comorbidity Population. A Stepwise Multiple-Choice System Approach.

Antioco Fois, Antoine Chatrenet, Emanuela Cataldo, Francoise Lippi, Ana Kaniassi, Jerome Vigreux, Ludivine Froger, Elena Mongilardi, Irene Capizzi, Marilisa Biolcati and 2 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Antioco FoisNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. antiocofois@gmail.com.
Antoine ChatrenetNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. antoine.chatrenet@gmail.com.
Emanuela CataldoNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. emanuela.cataldo@gmail.com.
Francoise LippiNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. flippi@ch-lemans.fr.
Ana KaniassiNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. akkaniassi@ch-lemans.fr.
Jerome VigreuxNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. jevigreux@ch-lemans.fr.
Ludivine FrogerNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. lfroger@ch-lemans.fr.
Elena MongilardiSCDU Urology, Department of Oncology, ASOU San Luigi, University of Torino, 10043 Orbassano, Italy. elenamongilardi@yahoo.it.
Irene CapizziNephrology, Department of Clinical and Biological Sciences, ASOU San Luigi, University of Torino, 10043 Orbassano, Italy. irene.ccapizzi@gmail.com.
Marilisa BiolcatiObstetrics, Department of Surgery, Città della Salute e della Scienza, University of Torino, Torino 10126, Italy. marilisa.biolcati@unito.it.
Elisabetta VersinoSS Epidemiology, Department of Clinical and Biological Sciences, ASOU San Luigi, University of Torino, 10043 Orbassano, Italy. elisabetta.versino@unito.it.
Giorgina Barbara PiccoliNéphrologie, Centre Hospitalier Le Mans, 72000 Le Mans, France. gbpiccoli@yahoo.it.ORCID 0000-0002-2632-4009
Centre Hospitalier du Mans · FRUniversity of Turin · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProtein restriction may retard the need for renal replacement therapy; compliance is considered a barrier, especially in elderly patients.

methodsA feasibility study was conducted in a newly organized unit for advanced kidney disease; three diet options were offered: normalization of protein intake (0.8 g/kg/day of protein); moderate protein restriction (0.6 g/kg/day of protein) with a "traditional" mixed protein diet or with a "plant-based" diet supplemented with ketoacids. Patients with protein energy wasting (PEW), short life expectancy or who refused were excluded. Compliance was estimated by Maroni-Mitch formula and food diary.

resultsIn November 2017⁻July 2018, 131 patients started the program: median age 74 years (min⁻max 24-101), Charlson Index (CCI): 8 (min-max: 2⁻14); eGFR 24 mL/min (4⁻68); 50.4% were diabetic, BMI was ≥ 30 kg/m² in 40.4%. Normalization was the first step in 75 patients (57%, age 78 (24⁻101), CCI 8 (2⁻12), eGFR 24 mL/min (8⁻68)); moderately protein-restricted traditional diets were chosen by 24 (18%, age 74 (44⁻91), CCI 8 (4⁻14), eGFR 22 mL/min (5⁻40)), plant-based diets by 22 (17%, age 70 (34⁻89), CCI 6.5 (2⁻12), eGFR 15 mL/min (5⁻46)) (

conclusionProtein restriction is feasible by an individualized, stepwise approach in an overall elderly, high-comorbidity population with a baseline high-protein diet and is compatible with stable nutritional status.

Indexed as

Diet, Protein-RestrictedAdultAgedAged, 80 and overComorbidityDisease ProgressionFemaleHumansKidney Failure, ChronicMaleMiddle AgedNutritional StatusPatient ComplianceRenal DialysisYoung Adultchronic kidney diseasecompliancediabetesobesityprotein intakeprotein restriction

Identifiers

PMID30586894
PMCPMC6356994
OpenAlexW2906150867

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.